User profiles for Luanne Metz

Luanne Marie Metz

University of Calgary
Verified email at ahs.ca
Cited by 19208

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

…, L Kappos, FD Lublin, LM Metz… - Annals of Neurology …, 2005 - Wiley Online Library
New diagnostic criteria for multiple sclerosis integrating magnetic resonance image
assessment with clinical and other paraclinical methods were introduced in 2001. The “McDonald …

A full genome search in multiple sclerosis

…, T Gray, P O'Connor, A Nath, A Auty, L Metz… - Nature …, 1996 - nature.com
The aetiology of multiple sclerosis (MS) is uncertain. There is strong circumstantial evidence
to indicate it is an autoimmune complex trait 1–3 . Risks for first degree relatives are …

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

V Brundula, NB Rewcastle, LM Metz, CC Bernard… - Brain, 2002 - academic.oup.com
Multiple sclerosis is characterized by the infiltration of leukocytes into the CNS. As matrix
metalloproteinases (MMPs) facilitate the passage of leukocytes across matrix barriers, we …

The promise of minocycline in neurology

…, F Giuliani, S Casha, C Power, LM Metz - The Lancet …, 2004 - thelancet.com
The capacity of minocycline to alleviate disease for several neurological disorders in animals
is increasingly being recognised. Indeed, that one drug alone can attenuate the severity of …

Endocrine disrupting chemicals and immune responses: A focus on bisphenol-A and its potential mechanisms

JA Rogers, L Metz, VW Yong - Molecular immunology, 2013 - Elsevier
Endocrine disrupting chemicals (EDCs) have become of concern for a variety f health issues.
Due to their effects on the endocrine system they have been thoroughly examined with …

Long-term medical conditions and major depression: strength of association for specific conditions in the general population

…, JVA Williams, C Barbui, LM Metz - The Canadian …, 2005 - journals.sagepub.com
Background: The prevalence of major depression (MD) in persons with nonpsychiatric medical
conditions is an indicator of clinical need in those groups, an indicator of the feasibility of …

Regional variation of multiple sclerosis prevalence in Canada

CA Beck, LM Metz, LW Svenson… - Multiple Sclerosis …, 2005 - journals.sagepub.com
Objective: To describe the regional distribution of multiple sclerosis (MS) prevalence in
Canada, controlling for age and sex. Methods: This study used data from the Canadian …

[HTML][HTML] Trial of minocycline in a clinically isolated syndrome of multiple sclerosis

LM Metz, DKB Li, AL Traboulsee… - … England Journal of …, 2017 - Mass Medical Soc
Background On the basis of encouraging preliminary results, we conducted a randomized,
controlled trial to determine whether minocycline reduces the risk of conversion from a first …

Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population

SB Patten, LM Metz, MA Reimer - Multiple Sclerosis Journal, 2000 - journals.sagepub.com
The objective of this paper was to evaluate the lifetime and point prevalence of major
depression in a population-based Multiple Sclerosis (MS) clinic sample, and to describe …

Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators

…, RK Zabad, S Agrawal, AG DaSilva, LM Metz - Journal of the …, 2007 - Elsevier
The matrix metalloproteinases (MMPs) are implicated in the pathology of multiple sclerosis (MS).
This review summarizes the consequences of upregulation of MMP members in MS as …